+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-01-27Number of Pages: 128

Platelet Rich Plasma Market – Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023


1. Introduction  
    1.1 Report Description
    1.2 Research Methodology
    1.3 Market Segmentation

2. Executive Summary
    2.1 Market Snapshot

3. Asia Pacific Platelet Rich Plasma Market Overview
    3.1 Introduction
    3.2 Value Chain Analysis
    3.3 Regulatory Framework
    3.4 Market Dynamics
         3.4.1 Drivers
         3.4.2 Restraints
         3.4.3 Opportunities
    3.5 Porter’s Five Force Analysis
         3.5.1 Bargaining Power of Buyers
         3.5.2 Bargaining Power of Suppliers
         3.5.3 Threat of New Entrants
         3.5.4 Threat of Substitutes
         3.5.5 Competitive Rivalry
    3.6 Market Attractiveness Analysis of the Asia Pacific Platelet Rich Plasma Market, by Country, 2014
    3.7 Competitive Landscape: Market Share Analysis by Key Players, 2014 (Value, %)

4. Asia Pacific Platelet Rich Plasma Market Revenue, by Type, 2013–2023 (US$ Mn)
    4.1 Overview
    4.2 Pure Platelet-Rich Plasma (P-PRP) Market Revenue, by Country, 2013–2023 (US$ Mn)
         4.2.1 Australia
         4.2.2 Philippines
         4.2.3 China
         4.2.4 India
         4.2.5 Singapore
         4.2.6 Thailand
         4.2.7 Malaysia
         4.2.8 Korea
         4.2.9 Hong Kong
         4.2.10 Taiwan
         4.2.11 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)
    4.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP)*
    4.4 Pure Platelet-Rich Fibrin (P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin (L-PRF)*

5. Asia Pacific Platelet Rich Plasma Market Revenue, by Origin, 2013–2023 (US$ Mn)
    5.1 Overview
    5.2 Autologous Platelet-Rich Plasma
         5.2.1 Australia
         5.2.2 Philippines
         5.2.3 China
         5.2.4 India
         5.2.5 Singapore
         5.2.6 Thailand
         5.2.7 Malaysia
         5.2.8 Korea
         5.2.9 Hong Kong
         5.2.10 Taiwan
         5.2.11 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)
    5.3 Allogeneic Platelet-Rich Plasma*
    5.4 Homologous Platelet-Rich Plasma*

6. Asia Pacific Platelet Rich Plasma Market Revenue, by Application, 2013–2023 (US$ Mn)
    6.1 Overview
    6.2 Orthopedic Surgery
         6.2.1 Australia
         6.2.2 Philippines
         6.2.3 China
         6.2.4 India
         6.2.5 Singapore
         6.2.6 Thailand
         6.2.7 Malaysia
         6.2.8 Korea
         6.2.9 Hong Kong
         6.2.10 Taiwan
         6.2.11 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)
    6.3 Cosmetic Surgery*
    6.4 General Surgery*
    6.5 Neurosurgery*
    6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal)*

7. Asia Pacific Platelet Rich Plasma Market Revenue, by Country, 2013–2023 (US$ Mn)
    7.1 Overview
    7.2 Australia
    7.3 Philippines
    7.4 China
    7.5 India
    7.6 Singapore
    7.7 Thailand
    7.8 Malaysia
    7.9 Korea
    7.10 Hong Kong
    7.11 Taiwan
    7.12 Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)

8. Recommendations

9. Company Profiles
    9.1 AdiStem Ltd.
    9.2 Arthrex, Inc.
    9.3 Biomet, Inc.
    9.4 Cesca Therapeutics, Inc.
    9.5 DePuy Synthes, Inc.
    9.6 Exactech, Inc.
    9.7 Harvest Technologies Corp.
    9.8 NeoGenesis Co. Ltd.
    9.9 Rmedica Co. Ltd.
    9.10 Stryker Corporation
    9.11 Seawon Meditech
    9.12 Others

*: Similar country wise analysis provided for all other segments


 
 
Back To Top